160 related articles for article (PubMed ID: 15611244)
1. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Piccoli M; Frati L; Santoni A
J Immunol; 2005 Jan; 174(1):223-32. PubMed ID: 15611244
[TBL] [Abstract][Full Text] [Related]
2. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
Villalba M; Kasibhatla S; Genestier L; Mahboubi A; Green DR; Altman A
J Immunol; 1999 Dec; 163(11):5813-9. PubMed ID: 10570264
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
7. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells.
Chow WA; Fang JJ; Yee JK
J Immunol; 2000 Apr; 164(7):3512-8. PubMed ID: 10725705
[TBL] [Abstract][Full Text] [Related]
8. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
9. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.
Li-Weber M; Laur O; Krammer PH
Eur J Immunol; 1999 Sep; 29(9):3017-27. PubMed ID: 10508276
[TBL] [Abstract][Full Text] [Related]
10. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
11. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
[TBL] [Abstract][Full Text] [Related]
12. Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression.
Pardo J; Buferne M; Martínez-Lorenzo MJ; Naval J; Schmitt-Verhulst AM; Boyer C; Anel A
Int Immunol; 2003 Dec; 15(12):1441-50. PubMed ID: 14645153
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B-dependent Fas ligand expression.
Hsu SC; Gavrilin MA; Lee HH; Wu CC; Han SH; Lai MZ
Eur J Immunol; 1999 Sep; 29(9):2948-56. PubMed ID: 10508269
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Gómez-Hernández A; Arribas A; Ortega L; Tuñón J; Egido J
Stroke; 2004 Feb; 35(2):458-63. PubMed ID: 14739407
[TBL] [Abstract][Full Text] [Related]
16. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells.
Harwood FG; Kasibhatla S; Petak I; Vernes R; Green DR; Houghton JA
J Biol Chem; 2000 Apr; 275(14):10023-9. PubMed ID: 10744679
[TBL] [Abstract][Full Text] [Related]
17. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.
Bodor J; Bodorova J; Bare C; Hodge DL; Young HA; Gress RE
Eur J Immunol; 2002 Jan; 32(1):203-12. PubMed ID: 11754361
[TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.
Kasibhatla S; Genestier L; Green DR
J Biol Chem; 1999 Jan; 274(2):987-92. PubMed ID: 9873041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
